Arecor Therapeutics plc (AIM:AREC)
London
· Delayed Price · Currency is GBP · Price in GBX 51.50
-1.00 (-1.90%)
Feb 21, 2025, 4:35 PM GMT+1
Arecor Therapeutics Revenue
Arecor Therapeutics had revenue of 2.00M GBP in the half year ending June 30, 2024, with 187.88% growth. This brings the company's revenue in the last twelve months to 4.90M, up 44.98% year-over-year. In the year 2023, Arecor Therapeutics had annual revenue of 4.57M with 90.30% growth.
Revenue (ttm)
4.90M
Revenue Growth
+44.98%
P/S Ratio
3.22
Revenue / Employee
97.98K
Employees
50
Market Cap
19.44M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| Hikma Pharmaceuticals | 2.39B |
| ConvaTec Group | 1.74B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |
Arecor Therapeutics News
- 5 months ago - Half Year 2024 Arecor Therapeutics PLC Earnings Presentation Transcript - GuruFocus